These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20564311)

  • 1. Comparative effectiveness research: Policy context, methods development and research infrastructure.
    Tunis SR; Benner J; McClellan M
    Stat Med; 2010 Aug; 29(19):1963-76. PubMed ID: 20564311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.
    Manchikanti L; Falco FJ; Boswell MV; Hirsch JA
    Pain Physician; 2010; 13(1):E23-54. PubMed ID: 20119474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facts, fallacies, and politics of comparative effectiveness research: Part 2 - implications for interventional pain management.
    Manchikanti L; Falco FJ; Boswell MV; Hirsch JA
    Pain Physician; 2010; 13(1):E55-79. PubMed ID: 20119475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.
    Manchikanti L; Falco FJ; Benyamin RM; Helm S; Parr AT; Hirsch JA
    Pain Physician; 2011; 14(3):E249-82. PubMed ID: 21587337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining comparative effectiveness research: the importance of getting it right.
    Sox HC
    Med Care; 2010 Jun; 48(6 Suppl):S7-8. PubMed ID: 20473202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promise and realities of comparative effectiveness research.
    Gatsonis C
    Stat Med; 2010 Aug; 29(19):1977-81; discussion 1996-7. PubMed ID: 20683886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.
    Ahmed S; Berzon RA; Revicki DA; Lenderking WR; Moinpour CM; Basch E; Reeve BB; Wu AW;
    Med Care; 2012 Dec; 50(12):1060-70. PubMed ID: 22922434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited article: comparative effectiveness research, evidence-based medicine, and the AAN.
    French JA; England JD
    Neurology; 2010 Aug; 75(6):562-7. PubMed ID: 20697109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of comparative effectiveness research in Asia, Europe, and North America.
    Patel I; Rarus R; Tan X; Lee EK; Guy J; Ahmad A; Chang J
    Indian J Pharmacol; 2015; 47(6):585-93. PubMed ID: 26729947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness research in practice and policy for radiation oncology.
    Lawrence WF
    Semin Radiat Oncol; 2014 Jan; 24(1):54-60. PubMed ID: 24314343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implications of comparative effectiveness research for academic medicine.
    Rich EC; Bonham AC; Kirch DG
    Acad Med; 2011 Jun; 86(6):684-8. PubMed ID: 21512362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving state Medicaid policies with comparative effectiveness research: a key role for academic health centers.
    Zerzan JT; Gibson M; Libby AM
    Acad Med; 2011 Jun; 86(6):695-700. PubMed ID: 21512359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating comparative effectiveness research into Medicaid payment policy: views from medical and pharmacy directors.
    Weissman JS; Westrich K; Hargraves JL; Pearson SD; Dubois R; Emond S; Olufajo OA
    J Comp Eff Res; 2015 Mar; 4(2):79-88. PubMed ID: 25825839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and challenges for comparative effectiveness research (CER) with Electronic Clinical Data: a perspective from the EDM forum.
    Holve E; Segal C; Hamilton Lopez M
    Med Care; 2012 Jul; 50 Suppl():S11-8. PubMed ID: 22692252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Looking at CER from Medicare's perspective.
    Mohr P
    J Manag Care Pharm; 2012 May; 18(4 Suppl A):S5-8. PubMed ID: 22578211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.
    Chalkidou K; Tunis S; Whicher D; Fowler R; Zwarenstein M
    Clin Trials; 2012 Aug; 9(4):436-46. PubMed ID: 22752634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness research: policy and politics.
    Zusman EE
    Neurosurg Focus; 2012 Jul; 33(1):E6. PubMed ID: 22746238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific and organizational collaboration in comparative effectiveness research: the VA cooperative studies program model.
    Huang GD; Ferguson RE; Peduzzi PN; O'Leary TJ
    Am J Med; 2010 Dec; 123(12 Suppl 1):e24-31. PubMed ID: 21184863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.